Emiel Ruijter
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Rheumatology top 5%
- Oncology
- Cancer Research
- Co-authors
- F.M.J. DebruyneJack A. SchalkenDirk J. RuiterC A van de KaaGary J. MillerJean de la RosetteHarrie P. BeerlageGeert J.L.H. van Leenders
- Topics
- Prostate Cancer Treatment and Research (6 papers)Prostate Cancer Diagnosis and Treatment (5 papers)Wnt/β-catenin signaling in development and cancer (4 papers)
- Partner nations
- NetherlandsUnited StatesJapan
In The Last Decade
Emiel Ruijter
16 papers receiving 818 citations
Peers
Comparison fields: 5 of 79
- Pulmonary and Respiratory Medicine 545
- Molecular Biology 234
- Rheumatology 192
- Oncology 112
- Cancer Research 103
Countries citing papers authored by Emiel Ruijter
This map shows the geographic impact of Emiel Ruijter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emiel Ruijter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emiel Ruijter more than expected).
Fields of papers citing papers by Emiel Ruijter
This network shows the impact of papers produced by Emiel Ruijter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emiel Ruijter. The network helps show where Emiel Ruijter may publish in the future.
Co-authorship network of co-authors of Emiel Ruijter
This figure shows the co-authorship network connecting the top 25 collaborators of Emiel Ruijter. A scholar is included among the top collaborators of Emiel Ruijter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emiel Ruijter. Emiel Ruijter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 11 | |
| 3 | 80 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 10 | |
| 7 | 28 | |
| 8 | 82 | |
| 9 | 45 | |
| 10 | 51 | |
| 11 | 146 | |
| 12 | 78 | |
| 13 | 40 | |
| 14 | 7 | |
| 15 | 61 | |
| 16 | 44 | |
| 17 | 148 |
About Emiel Ruijter
Emiel Ruijter is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Urology, having authored 17 papers that have together received 835 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (6 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Wnt/β-catenin signaling in development and cancer (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (545 citations), Rheumatology (192 citations) and Cancer Research (103 citations). Emiel Ruijter has collaborated with scholars based in Netherlands, United States and Japan. Frequent co-authors include F.M.J. Debruyne, Jack A. Schalken, Dirk J. Ruiter, C A van de Kaa, Gary J. Miller, Jean de la Rosette, Harrie P. Beerlage, Geert J.L.H. van Leenders, J.A. Witjes and Gosse O.N. Oosterhof. Their work appears in journals such as Endocrine Reviews, The Journal of Urology and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.